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M
ost of the commercially available
technologies for point-of-care (POC)
immunoassays center around lateral
flow devices. Lateral flow immunoassays
consist of prefabricated strips containing
immobilized antigen and antibodies as
well as nanoparticles.1 The presence of an
antibody in a specimen is recognized by
binding to a region on the test strip and
visualized using color-generating nanoparti-
cle based labels. However, this simple testing
method has some inherent weaknesses
compared to enzyme-linked immunosorbent
assay (ELISA) based tests. First, lateral flow
assays (LFAs) are much less sensitive than
ELISA because a larger amount of antibody
antigen interactions needs to occur to create
a visible signal. Second, most of the com-
mercially available LFAs provide qualitative
analyte assessment. This limits the useful-
ness for vaccine effectiveness and many
infectious disease diagnostics, because a
semiquantitative or quantitative assess-
ment is clinically important. Finally, LFA
tests are only designed for single test
use, which makes large-scale screening of
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ABSTRACT Standard microplate based enzyme-linked immuno-
sorbent assays (ELISA) are widely utilized for various nanomedicine,
molecular sensing, and disease screening applications, and this
multiwell plate batched analysis dramatically reduces diagnosis
costs per patient compared to nonbatched or nonstandard tests.
However, their use in resource-limited and field-settings is inhibited
by the necessity for relatively large and expensive readout instru-
ments. To mitigate this problem, we created a hand-held and cost-effective cellphone-based colorimetric microplate reader, which uses a 3D-printed opto-
mechanical attachment to hold and illuminate a 96-well plate using a light-emitting-diode (LED) array. This LED light is transmitted through each well, and
is then collected via 96 individual optical fibers. Captured images of this fiber-bundle are transmitted to our servers through a custom-designed app for
processing using a machine learning algorithm, yielding diagnostic results, which are delivered to the user within ∼1 min per 96-well plate, and are
visualized using the same app. We successfully tested this mobile platform in a clinical microbiology laboratory using FDA-approved mumps IgG, measles
IgG, and herpes simplex virus IgG (HSV-1 and HSV-2) ELISA tests using a total of 567 and 571 patient samples for training and blind testing, respectively, and
achieved an accuracy of 99.6%, 98.6%, 99.4%, and 99.4% for mumps, measles, HSV-1, and HSV-2 tests, respectively. This cost-effective and hand-held
platform could assist health-care professionals to perform high-throughput disease screening or tracking of vaccination campaigns at the point-of-care,
even in resource-poor and field-settings. Also, its intrinsic wireless connectivity can serve epidemiological studies, generating spatiotemporal maps of
disease prevalence and immunity.
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populations based on LFA tests expensive and time-
consuming.
Immunoserological analysis at the nanoscale is a
critical component to diagnostic testing within a
health care setting. Centralized laboratory testing by
ELISA in a standard 96-well plate format allows for
high-throughput and accurate antibody or antigen
recognition for the diagnosis of many important in-
fectious diseases, including herpes simplex virus (HSV),
and vaccine effectiveness surveillance for re-emerging
diseases such as measles and mumps.24 These labo-
ratories require a large, integrated infrastructure in-
cluding robotic systems, liquid handlers, and multiwell
scanning spectrophotometers to prepare and analyze
samples in batch, which currently is only available in
high resource capacity regions. POC immunoserologi-
cal assays are available in resource limited settings, but
these devices often sacrifice accuracy and can only test
a limited number of patients. As the rate of infectious
disease continues to increase in resource limited set-
tings, there is a need for high-throughput and accurate
POC antibody recognition and nanosensing platforms.
Various POC ELISA approaches have been devel-
oped recently based on e.g., microfluidic platforms or
paper-based devices, among others, in order to im-
prove accessibility in resource-limited or remote
areas.510 Perhaps the most advanced work to date
has also shown the ability to integrate a microfluidic
ELISA platform with a smartphone dongle that could
provide several functions including pumping and ima-
ging of a silver precipitation readout of sandwich
ELISA.11 This approach was applied to triplex serologi-
cal analysis achieving good agreement with gold stan-
dard ELISA testing. However, using a nonstandard
disposable cartridge per patient remains relatively costly
compared to standard multiwell plate based ELISA test-
ing especially for community-wide screening and vac-
cine effectiveness monitoring efforts. The sensitivity of
ELISA has also been tremendously improved in the past
several decades with limits of detection approaching
the single molecule limit by either compartmentalizing
the assay into smaller volumes, a method known as the
digital ELISA,12,13 or by amplifying the color change,
utilizing surface plasmon enhancement effect.14
Despite all the promising results obtainedwith these
emerging approaches, 96-well plate based ELISA still
remains the standard and most cost-effective tool in
clinical laboratories for diagnosing diseases and mon-
itoring the result of interventions, such as for vaccine
efficacy screening. Even with an initially large capital
investment, multiwell plate ELISAs are the standard
format in clinical laboratories because sample batching
and reduction in manual labor and consumables are
extremely cost-effective. Additionally, multiwell plate
implementations of a broad range of ELISA tests are
already FDA-approved, easing future regulatory bur-
den for adaptations of these tests.
Scanning based spectrophotometry is the standard
method to read colorimetric ELISA signals from 96-well
plates and it requires a relatively expensive and bulky
benchtop reader to individually scan each well and
a reliable power grid, seriously limiting the usefulness
of this method in resource-limited or remote settings.
Alternatively, imaging-based detection methods which
capture the entire plate in a single shot by using either a
digital camera1517 or a flatbed scanner18 have been
developed. Optical imaging methods are favorable for
rapid diagnostic purposes; however, the miniaturiza-
tion of these existing imaging systems into a self-
contained and robust hand-held unit remains a major
challenge due to the difficulty of creating a wide field
of view (FOV) image that can span the entire plate
area (127  85 mm2) in a compact, lightweight and
cost-effective design, with minimal optical aberra-
tions. Moreover, the ideal POC well plate reader plat-
form would also benefit from integrating additional
functionalities such as on-site image processing, wire-
less connectivity, and a smart user-interface for immedi-
ate reporting, sharing, and spatiotemporal labeling/
archiving, as well as visualization of diagnostic results
for, e.g., telemedicine and POC screening applications.
Suchahand-held, cost-effective, and fully integratedplate
reader system, however, has not yet been demonstrated.
Recent advances in consumer electronics and
wireless communication devices have cultivated a
transformation in biomedical imaging, sensing and
diagnostics.19 By leveraging the power of semiconduc-
tor sensor chips and carry-on optics, mobile-phone
based devices have become a versatile microscopy/
nanoscopy and sensing platform for a wide range of
applications,1924 including blood analysis,25,26 bacteria
detection,27 single-virus imaging,28 DNA imaging and
sizing,29,30 chemical sensing,3134 and biomarker
detection,6,35,36 among others.3743 Smartphones
have also been used to illuminate and image well-
plate based ELISA tests.44,45 However, these previous
demonstrations are not hand-held and are in fact
based on a bulky imaging geometry, which exhibits
optical aberrations due to the large field-of-view, also
degrading the sensitivity especially for wells that are
closer to the edges of the multiwell plate. In general, it
is also possible to use the camera of the mobile-phone
to capture an image of the well-plate array in ambient
light conditions or using an external lamp without an
additional optical design.46 However, this simple ap-
proach has severe limitations in terms of repeatability
and detection sensitivity, both of which will depend on
(i) the user (e.g., in the form of uncontrolled variations
in camera field-of-view and related tilts and motion
artifacts), and (ii) the external lighting conditions (e.g.,
day vs night). As a result of these limitations, no results
frompatient testing have been reported so far with this
simple camera based standardmultiwell plate imaging
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Here, we demonstrate a cost-effective and hand-
held smartphone-based colorimetric reader for rapid
monitoring of microtiter plate (MTP) based colori-
metric ELISA immunoassays. We created a unique
optical fiber array based smartphone attachment to
capture the transmitted light fromeachwell of theMTP
by the smartphone camera. When compared with
other microplate readers, this design provides a sig-
nificantly more compact and lightweight imaging plat-
form, and does not suffer fromoptical aberrations since
the 96-well plate is transformed into an imaging area at
the end of the fiber-bundle that is >110-fold smaller
compared to the actual area of the well plate. Our
device utilizes blue LEDs as the light illumination array
and is operated completely by battery power. We
demonstrated the application of this device for mon-
itoring four common clinical ELISA tests: measles IgG,
mumps IgG, and herpes simplex virus IgG (i.e., HSV1
and HSV2). We also created a Windows phone based
smart app that can return the quantitative clinical index
values calculated from a calibration curve and the
qualitative Positive/Equivocal/Negative tripartite diag-
nostic decisions via a machine learning algorithm. By
comparing the test results of our mobile-phone reader
with the readout from a benchtop FDA approved
clinical plate reader, we achieved an overall accuracy
of 99.6%, 98.6%, 99.4%, and 99.4% formumps,measles,
HSV-1, and HSV-2 tests, respectively. This mobile de-
vice that is designed to read the colorimetric end point
of a 96 well plate format could easily expand to other
FDA-approved ELISA kits for disease diagnosis in POC
testing, potentially revolutionizing high-throughput
testing and nanosensing capabilities in low-resource
and field-settings.
RESULTS AND DISCUSSION
Optical Imaging Hardware. Our ELISA colorimetric sys-
tem (Figure 1) is composed of a Windows based
smartphone (Lumia 1020, Nokia), paired with a porta-
ble 3D printed attachment to package together optical
components, and a cloud connected data processing
server in communication with a custom mobile appli-
cation that serves as an interactive user interface. The
hand-held nature of our ELISA colorimetric reader
allows for use in the field, away from sophisticated
machinery, but the data processing speed is partially
limited by the computational hardware and the soft-
ware available for use on the cell phone. To resolve this
partial limitation while also maintaining portability, we
used a server for data processing and a wireless net-
work (e.g., cellular data,Wi-Fi) for data transfer between
the server and the mobile application (see Figure 2).
Figure 1A illustrates our 3D printed device which
consists of three separate parts: the top part, which
primarily functions as the holder for the cell phone, the
bottom of the device, which houses the fiber optic
array, and the middle chamber to load a 96 well plate,
which is illuminated vertically by an LED array consist-
ing of 24 uniformly distributed blue LED's (peak wave-
length, 464 nm). This system is powered using 6 AAA
batteries and there is a low-noise, low-dropout linear
current regulator in the system that provides constant
power to all 24 LEDs. Tomaximize the uniformity of the
illumination from the LED array, each LED is centered
against 4 wells on the plate, and the illumination light
was further homogenized by passing through two
layers of plastic diffusers before reaching the plate.
During each test, the 96-well ELISA plate of interest is
inserted through the back of the device, as shown in
Figure 1A. Blue light is transmitted through the well
and is then coupled into the optical fibers, which guide
the transmitted light to the external collection lens
(focal length 45 mm) that is placed in front of the
cellphone camera (upper right of Figure 1A). This fiber-
optic imaging geometry yields a demagnification fac-
tor of approximately 11-fold within a rather compact
and folded imaging design, which significantly reduces
the height of the entire reader. The transmitted light
through this fiber optic array is captured using the
cellphone camera (41 megapixel, pixel size of 1.12 μm)
in a RAW 10-bit/channel Digital Negative (DNG) image
format. Figure 1E shows an example of an image taken
by our system. The sample plate corresponding to
this image is also shown in Figure 1F. The overall
dimensions of our mobile reader are ∼195  98 
100 mm3. Figure 1BD also shows different perspec-
tives of the actual device with a US quarter used for
scale comparison.
Figure 1. Schematic overview (A) anddifferent perspectives
(BD) of the cellphone based ELISA colorimetric reader.
Sample image (E), and sample plate (F). Rows and columns
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A comparison of our cell-phone based ELISA reader
against some of the commercially available ELISA
readers4749 is also provided in the Supporting Infor-
mation (Table S1). One of the smallest of these com-
mercially available readers is the Bio-Rad PR 4100,
which measures 134  347  187 mm3 with a weight
of 2.58 kg.47 In comparison, our device design reduces
the overall volume of the reader instrument by a factor
of 4.54 and the weight by a factor of 4.17.
Data Processing via Smartphone Application and Server.
Figure 2 illustrates the communication between the
cellphone and the server, and the flowchart of data
processing carried out in the server to obtain the final
clinical quantitative values. First, the ELISA plate is
inserted into the device and images are captured at
three different exposure times (dim (τD) 1/1600 s,
moderate (τM) 1/1250 s, and bright (τB) 1/800 s) using
the Nokia Pro Camera application and saved on the
phone using the RAWDNG image format (7152 5360
pixels) (Figure 2A). To process these images, the user
runs our custom-developed application. Figure 3
shows screenshots of this colorimetric plate reader
application: from the main menu (Figure 3A), the user
can process a new test or review previously run tests.
When starting a new test, the user first selects the dim,
moderate, and bright images to use (see Figure 3B).
Next, the user specifies the type of immunoassay being
tested (i.e.,measles IgG,mumps IgG,HSV-1, orHSV-2 IgG),
the column location of their tests in the well plate, and
any conversion factors provided by the kit manufacturer,
and then submits the test to the server for processing.
After receiving this new test request, the server
(implemented in Python using the Twisted framework)
waits for the DNG test files to finish uploading before
processing. These DNG images are first converted to
tagged image file format (TIFF) for easier extraction of
the blue channel of the image. The blue channel pixel
intensities (Figure 2B) are extracted from the raw
images by localizing the Bayer pattern and defining
its orientation. From the blue channel image, the
average pixel intensity of each individual well is ob-
tained. To do so, the centroids of each well are auto-
matically detected using a custom designed algorithm.
Since some centroids will randomly have low light
intensity, a basic intensity thresholding method is not
sufficient to accurately determine the position of all the
96 wells. Therefore, our custom-designed algorithm
finds two reference centroids as ELISA plate markers
using pixel intensity thresholding in combination with
morphological erosion-dilation operations50 to sepa-
rate overlapping wells. We selected the most upper
right and the most lower right wells as reference
centroids, and using their coordinates, the algorithm
is able to match the positions of all the remaining
Figure 2. Flowchart showing the data processing steps of our reader. From the raw images (A), the blue channel (B) is
extracted to be used for the rest of the data processing. Dividing the intensities of each well by the intensity of the brightest
well, a raw intensity map (C) of blue pixel values is generated. Next, by normalizing everything to a control, a scaled intensity
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centroids by performing alignment/rotation correc-
tions on 96 previously calculated blank plate centroids.
Once these centroids are detected, a circularmaskwith
a 15 pixel radius, which is a few pixels smaller than the
radius of the well, is used to prevent edge related
artifacts in our data processing.
Once the blue channel information is extracted, the
dim, moderate, and bright average intensities per well
(i.e., ID, IM, and IB, respectively) are combined to pro-
duce a high dynamic range (HDR) image. This is
achieved through addition of each intensity after being
scaled by the brightest well for that exposure time
(Figure 2C), where ID‑MAX is the highest well intensity
of all the wells in the dim exposure time τD; IM‑MAX
and IB‑MAX follow the same convention. To normalize
against imaging system-induced changes on, e.g., well
transmittance, we also imaged blank reference wells
with deionized (DI) water, which is a step performed
only once for a given reader. After this normalization
step, each cell in the scaled intensity map (Figure 2D)
will have a value between 0 and 1. With the use
of this scaling convention, a 1 represents complete
transmittance relative to DI water control, while a 0
represents no transmittance reading.
The last step in our processing is to convert the
optical density (OD) and transmittance values to a
quantified index value used for clinical decisions. This
conversion fromOD to clinical index value is definedby
the manufacturer of each immunoassay. The param-
eters used for this conversion to the final quantitative
index value are the optical densities of three calibration
wells and a test specific predetermined conversion
factor. Finally, amatrix of these quantified clinical index
values (one for each well) is transmitted back to the
cell phone for the user to view through the same app
(Figure 2E).
For the process of making qualitative clinical deter-
minations, we have approached the problem using
two different methods. The first method applies a
threshold identical to the threshold of the original
ELISA assay but based on the clinical index values
obtained by our cellphone reader (Figure 2E). A clinical
index value between 0.9 and 1.1 results in an equiv-
ocal determination, negative below 0.9, and positive
Figure 3. Screenshots from the Colorimetric Plate Reader app. (A) Mainmenu. (B) Image selection page for selecting the dim,
moderate, and bright exposure images to start a new test. (C) Parameter page for selecting the assay type (e.g., measles,
mumps, HSV1, and HSV2), calibration values, and test column positions. (D) The history page displays submitted and
processed tests on the server with their time of submission and test types. (E and F) Result display page showing either
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above 1.1. In addition to this curve-fitting and thresh-
old based diagnostic decisions, we also employed a
machine learning algorithm to make clinical determi-
nations using a total of 58 spatial features that are
automatically extracted from cellphone images. This
second approach (Figure 4) makes no assumptions of a
calibration function and increases its diagnostic accu-
racy as training sample size increases.
The goal of this machine learning framework is to
estimate the correct diagnostic label corresponding to
each test set and every time a new test is performed, a
test data set is created by extracting the same spatial
features used for the training data set. We used an
adaptive boosting machine learning algorithm,51
which statistically learned from the training data set
and estimated a diagnosis from each entry contained
in the test data (see Figure 4). This algorithm provides
accurate diagnosis by establishing statistical relations
between the features of the training data set and the
gold standard diagnostic labels. These statistical rela-
tionships are then applied to the features of the test
data to make a blind diagnostic decision. The main
advantage of using adaptive boosting based machine
learning algorithms is their capability to detect the
most promising features and discard others that may
degrade the accuracy of the results. Consequently, the
dimensionality of the statistical model is reduced and
the accuracy of the final predictions is boosted.
Figure 5. Comparisonbetween the cell phonemeasured clinical values and the reference clinical values,measuredby an FDA
approved clinical spectrophotometer.
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Clinical Testing. Our colorimetric cell-phone based
system has shown the ability to reach high accuracy
levels, ∼99100%, for the detection of measles IgG,
mumps IgG, HSV-1 IgG, and HSV-2 IgG, with a total
runtime of ∼1 min on our server (Intel Core i5-760,
2.8 GHz, 16GB RAM) per each 96-well plate. Figure 5
shows our mobile-phone reader results obtained for
these ELISA tests. The left column in Figure 5 repre-
sents the cell-phone index value versus the reference
index value (both in arbitrary units), while the right
column expresses the error detected between the
results obtained by our mobile system and our gold
standard, which is an FDA approved clinical spectro-
photometer. On each graph, the clinically relevant
linear-response region of each test, determined by
their manufacturer, is also indicated.
Looking at the plots of the reference index value
versus the cell phone measured index value shown in
Figure 5, one can see that there is a strong correlation
between the two readings and that there is an overlap,
as expected, in the region of linearity between the two
methods. The percentage difference plots shown in
the right column of Figure 5 also illustrate that, as
desired, there is no concentration dependent bias
between the two measurement methods. Further-
more, outside of the blue highlighted ranges shown
in Figure 5, a linear response is not expected for any
read-out method or instrument, and that is why
the deviation of the correlation between our mobile-
phone based measurements and the reference meth-
od is not significant from the perspective of diagnostic
classifications/decisions. In fact, as summarized in
Table 1, by using thresholds in our clinical index value
space, where C < 0.9, C > 1.1 and 0.9 < C < 1.1 define
negative, positive, and equivocal samples, respectively,
we can achieve very strong agreements in our diag-
nostic decisions for all the tests against the gold
standard well plate reader. These results can be further
improved by analyzing the spatial features of the
acquired cellphone images using a machine learning
algorithm as detailed earlier. Indeed, Table 1 reports
the significant improvements that we achieve in over-
all accuracy, specificity and sensitivity of our diagnostic
decisions by replacing simple threshold based deci-
sions with machine learning analysis, which take into
account 58 spatial features for each test well to arrive a
statistically trained and optimized ternary diagnostic
decision.
According to Table 1, for mumps IgG samples, our
machine learning algorithm achieves a 99.61% agree-
ment to the FDAapproved referencemethod. Formeasles
samples, the agreement percentage is 98.56%. Similarly,
forHSV-1 IgGandHSV-2 IgG results,weobtainagreements
of 99.42% and 99.41%, respectively. The sensitivity and
specificity performance of ourmachine learning approach
is also better than the curve fitting based threshold
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tests. The relatively lower specificity of mumps IgG
(97.37%) andmeasles IgG (94.56%) tests obtained from
our machine learning approach can be partially attrib-
uted to the smaller sample sizes in these tests com-
pared to HSV-1 IgG and HSV-2 IgG tests.
CONCLUSION
Using a cellphone and a 3D printed custom-
designed opto-mechanical platform to illuminate and
image a standard 96 well plate, we achieved an overall
accuracy of ∼99% or higher for HSV 1 IgG, and 99.4%
for HSV 2 IgG tests. These results illustrate that our
hand-held and cost-effective system is able to match
the performance of a conventional FDA approved
ELISA reader and give accurate diagnostic results to
the users in approximately 1 min. Following the same
calibration and testing procedures detailed in our
Methods section, our system should be able to achieve
similar results for other diseases normally tested via
standard ELISA techniques.
These results are especially timely considering the
recent re-emergence of measles. The United States has
shown a 600% increase inmeasles cases in 2014 due to
lack of regular vaccinations. It is critical from a public
health perspective to know exactly how many people
are effectively protected frommeasles to avoid further
outbreaks. The presence of measles IgG (as assayed in
this study) above an FDA defined threshold ensures
protected status from this deadly reemerging disease.
The availability of a hand-held and cost-effectivemulti-
well plate reader allows for high-throughput vaccine
surveillance outside of centralized areas and at the point
of care. This is also critical in an outbreak to rapidly
determine the number of susceptible (IgG negative)
people immediately exposed to an active measles case.
Measles is highly contagious inunvaccinated individuals
and can have a mortality rate as high as 1:1000.
The mobile device reported in this study could also
expand vaccination testing to rural areas that do not
have access to centralized testing laboratories with
large-scale spectrophotometers. The 96 well plate
ELISA format is the gold standard for high-throughput
antibody screening due to the extreme cost savings
associated with batch testing and economies of scale
compared to nonstandard or nonbatched cartridges or
microchips. Our cellphone-based hand-held micro-
plate reader brings this capability to resource limited
areas and makes high-throughput point of care ELISA
testing a reality. In addition, this device could be
immediately useful in support of large-scale vaccina-
tion efforts in the developingworld including trials and
implementation of the tetravalent dengue vaccine.
Such global health related efforts need to be coupled
with a high-throughput, mobile and cost-effective
ELISA screening device to ensure vaccine effectiveness
and help eradicate disease.
One limitation of this work is that it relies on pipet-
ting for loading of each well of the microplate of
interest, and sample preparation and loading steps
have not yet been integrated onto our mobile-phone
based instrument. This limitation will be addressed in
future work. Microfluidic automation can now perform
complex liquid handling steps powered by simply
drawing a vacuum in a syringe.52 Furthermore, new
methods for automated on-chip fluid manipulation
such as acoustofluidic micromixing53 and pumping54
have been emerging, and commercial products have
already integrated microfluidic systems into well plate
formats.55 Low-cost robotic liquid handler systems are
also now becoming more commonplace, leveraging
the consumer activities of the DIYBio and Maker
communities56 and the prevalence of low-cost micro-
controllers (e.g., Arduino).57,58 Our current focus on the
optical readout automation, replacing bulky and ex-
pensivemultiwell scanning spectrophotometers with a
hand-held design, addresses a key bottleneck in tran-
sitioning batched well-plate ELISA tests to field and
resource poor settings, enabling standardization and
economies of scale to act favorably outside of major
urban centers in the U.S. and abroad.
METHODS
Study Design. We tested our colorimetric cell-phone based
microplate reader platform in a clinical microbiology lab to
demonstrate detection of measles IgG, mumps IgG, HSV-1 IgG,
and HSV-2 IgG. Samples were prepared and tested at the UCLA
Clinical Microbiology Laboratory using standard procedures
for each test (Wampole Laboratories Mumps IgG ELISA II,59
Wampole Laboratories Measles IgG ELISA II,60 Focus Diagnostics
HerpeSelect 1 ELISA IgG,61 and Focus Diagnostics HerpeSelect
2 ELISA IgG62). For each disease, we quantified the performance
of our approach by calculating accuracy, specificity and sensi-
tivity values of our diagnostic decisions, where the results of an
FDA approved well plate reader (DSX Automated ELISA system,
Dynex Technologies) served as our gold standard. To minimize
degradation of data quality due to elapsed time, all the clinical
samples reported in this work were imaged by our mobile-
phone platform in less than 30 min after the same sample was
analyzed by the benchtop commercial plate reader. All these
experiments were performed at UCLA Clinical Microbiology
Laboratory by a medical personnel who did not develop the
platform but was trained on how to operate our platform. For
our performance calculations and comparisons, accuracy is
defined as the number of true positives and true negatives
divided by the total number of positives and negatives. Sensi-
tivity is calculated as true positives divided by true positives plus
false negatives, and specificity is calculated as true negatives
divided by true negatives plus false positives. Note that since
our gold standard technique sometimes is not able to accu-
rately determine a positive or negative diagnosis, the equivocal
test results of the reference technique are removed from our
performance calculations, since these individual measurements
do not present clinically interpretable results.
Calibration and Calculation of Test Results. For calibration of our
platform, ELISA wells with known OD values were used.
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values obtained by our benchtop plate reader was established
for each test to arrive at a calibration function. Calibration curves
obtained for each IgG assay, which follow a logarithmic fitting
that is based on the Beer's law, are presented in the Supporting
Information (Figure S1). Each calibration curve maps the HDR
normalized result obtained from our cell-phone system (i.e., C)
to the optical density value at 650 nm given by gold standard
clinical reader. For each type of test, we used approximately
half of the measurements for calibration and the other half for
blind validation. On the top of each graph, the number of
samples (N) used to build each calibration curve is also stated:
130 for mumps IgG, 133 for measles IgG, 154 for HSV-I IgG, and
150 for HSV-II IgG. Also note that the dynamic range for each IgG
ELISA test is different: HSV-I IgG and HSV-II IgG cover a wide OD
range between 0 and 4, while mumps and measles cover 03
and 02 ranges, respectively.
Machine Learning Algorithm. In ourmachine learning approach,
a custom designed algorithm automatically detects each well
center on the image, and calculates the average, standard
deviation, maximum, minimum, and maxmin difference of
the blue channel intensities to be used as training features
(Figure 4). In addition, as shown in Figure 2, each test consisted
of three cellphone pictures at different exposure times (τD, τM,
τB); so this feature extraction was repeated over these three
images separately, including the resultant HDR value of each
well used as additional features. Moreover, this process was
repeated using three different circular mask dimensions (with
10, 15, and 25 pixel radius) over each well center (see Figure 4).
Finally, the cell-phone clinical values (C) were also included in
the feature pool, providing a total of 58 spatial features for
characterization of each well.
Comparison of Diagnostic Decisions and Statistical Analysis. To com-
pare the diagnostic performance of our mobile-phone based
ELISA reader platform, we analyzed 10 random trials by splitting
the available clinical measurement data in half for each disease.
In other words, for each trial, half of the available data set
was allocated toward training and the other half toward blind
testing. This data splitting was carried out using a cross-valida-
tion technique63 that provides optimized training sets. Due to
the statistical nature of this cross-validation method, each trial
has a different and randomly selected training set.
Finally, logarithmic calibration curve equations and R-Squared
values reported in the Supporting Information were calculated
using Microsoft Excel curve fitting tools.
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